Holen Sie sich die Stockscreener-App
2.02
10.38%
0.19
Handel nachbörslich:
1.95
-0.07
-3.47%
20 20 Biolabs Inc Aktie (AIDX) Neueste Nachrichten
20/20 Biolabs (AIDX) CFO receives 100,000-share stock option grant - stocktitan.net
COO of 20/20 Biolabs (AIDX) granted 150,000 options at $1.88 - stocktitan.net
Resale of 10.1M 20/20 Biolabs (Nasdaq: AIDX) shares amid losses - stocktitan.net
AIDX : 20/20 Biolabs Inc. Key Company Metrics & Non-finance Metrics - Zacks Investment Research
20/20 Biolabs, Inc. (AIDX) stock price, news, quote and history - Yahoo Finance Singapore
AIDX: 20/20 Biolabs Inc.Financial Overview - Zacks Investment Research
20/20 BioLabs (AIDX) Reports 17% Revenue Growth in 2025 and Eyes Significant Expansion in 2026 with AI-Powered Cancer Detection Blood Tests - Minichart
20/20 BioLabs (AIDX) grows 2025 revenue 17% and narrows annual net loss - stocktitan.net
20/20 Biolabs 10-K: Revenues $2.05M, Net Loss $(3.74)M - TradingView
20/20 Biolabs (NASDAQ: AIDX) outlines AI blood tests, longevity and growth - Stock Titan
20/20 Biolabs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress - The Manila Times
Maryland funds firefighter cancer tests as 20/20 lifts margins - stocktitan.net
AIDX | 20/20 Biolabs, Inc. Common Institutional Ownership - Quiver Quantitative
20/20 BioLabs announces grants for Maryland fire departments to procure OneTest - TipRanks
Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs’ OneTest ™ Multi-Cancer Early Detection Blood Test - The Manila Times
Maryland funds cancer blood tests for more than 1,400 firefighters - stocktitan.net
20/20 BioLabs licenses kidney disease prediction technology from ROKIT Healthcare - MSN
Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs' OneTest Multi-Cancer Early Detection Blood Test - Bitget
20/20 BioLabs licenses kidney disease prediction technology By Investing.com - Investing.com Canada
What's going on with 20/20 Biolabs stock? - MSN
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
20/20 BioLabs enters exclusive technology license, access agreement with Rokit - TipRanks
What's Going On With 20/20 Biolabs Stock? - Benzinga
20/20 Biolabs Faces Decline Amid Market Rut - timothysykes.com
20/20 BioLabs licenses kidney disease prediction technology - Investing.com
20/20 Biolabs shares are trading lower after ... - Benzinga
20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program - The Manila Times
20/20 BioLabs Announces Exclusive U.S. License Agreement - GlobeNewswire
What is the current Price Target and Forecast for 20/20 Biolabs Inc. (AIDX) - Zacks Investment Research
What date does 20/20 Biolabs Inc.'s (AIDX) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
AIDX Stock Price, News & Analysis - Stock Titan
Debt to equity ratio of 20/20 Biolabs, Inc. – NASDAQ:AIDX - TradingView
20/20 Biolabs Inc. (AIDX) Total Long Term Debt (Quarterly) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Return On Assets (TTM) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Total Expenses (TTM) - zacks.com
20/20 Biolabs Inc. (AIDX) Price Book Value - Zacks Investment Research
Cash per share of 20/20 Biolabs, Inc. – NASDAQ:AIDX - TradingView
Michael A. Ross Net Worth (2026) - GuruFocus
Michael Saul Lebowitz Net Worth (2026) - GuruFocus
Jonathan M Cohen Net Worth (2026) - GuruFocus
Prasanth Reddy Net Worth (2026) - GuruFocus
Jiming Zhou Net Worth (2026) - GuruFocus
20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies - Sahm
20/20 Biolabs, Inc. Revenue Breakdown – NASDAQ:AIDX - TradingView
Analysts Offer Insights on Healthcare Companies: 20/20 Biolabs, Inc. (AIDX) and Biogen (BIIB) - The Globe and Mail
20/20 BioLabs provides update on protein biomarket technology for MCED - TipRanks
Blood test using proteins aims to catch cancer years earlier than DNA screens - stocktitan.net
Jonathan Cohen Discloses Investment at 20/20 Biolabs with 16.8% Stake - TradingView
Full Succeed (AIDX) owns 6.3% — 651,465 shares disclosed in Schedule 13G - stocktitan.net
20/20 Biolabs (AIDX) CEO awarded 352,936-share stock option grant - Stock Titan
20/20 Biolabs Inc. (AIDX) Revenue (Quarterly) Yoy Growth - Zacks Investment Research
20/20 Biolabs (AIDX) 10K Form and SEC Filings 2026 - MarketBeat
20/20 Biolabs Inc. (AIDX) Free Cash Flow (TTM) - Zacks Investment Research
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
20/20 Biolabs Inc. (AIDX) Price To Cash Flow - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Net Income (Quarterly) - Zacks Investment Research
AIDX News Today | Why did 20/20 Biolabs stock go up today? - MarketBeat
20/20 Biolabs (AIDX) Stock Price, News & Analysis - MarketBeat
20/20 Biolabs Inc. (AIDX) Cash From Operations (TTM) - Zacks Investment Research
Number of employees of 20/20 Biolabs, Inc. – NASDAQ:AIDX - TradingView
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):